Biomarker Platform Articles & Analysis
13 news found
“I am thrilled to be joining Bodyport, to work alongside such a passionate, mission-driven, and innovative team to bring our platform to heart disease patients and their clinical teams,” said Amit Rushi. “Bodyport is pioneering an incredibly intuitive care management platform to make a meaningful difference in the quality of care for ...
Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, announced today the appointment of Jim Pursley to the company’s board of directors. ...
Bodyport, a digital therapeutics company on a mission to address complex chronic conditions, announced today that its noninvasive biomarker platform, the Bodyport Cardiac Scale™ received U.S. Food & Drug Administration (FDA) 510(k) clearance. ...
John Lipman: We plan on developing new biomarkers and algorithms that help better predict worsening status in patients living with complex chronic conditions. New biomarkers and algorithms will enable us to detect adverse events earlier and more precisely, further enhancing our ability to keep patients out of the hospital and in their homes. ...
Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, today announced the appointment of medtech industry veteran, John Lipman, as Chief Executive Officer. ...
The Alzheimer's Podcast is available on all major podcast platforms including Apple Podcasts, Google Podcasts, Amazon Music and Spotify, as well as HealthUnmuted.com. ...
Chadha will lead all clinical and medical affairs as the company continues to develop, validate, and commercialize its AI-driven digital biomarker platform. She will report directly to the Chief Executive Officer of Altoida, Travis Bond, and will serve on the Leadership team. ...
Joint research of biomarkers on platform technology of GI Innovation, GI-SMART™, and SpAC9 Pipeline, AI-powered biomarker discovery platform of CellKey Prediction of drug response on next-generation immuno-oncology, personalized cancer treatment effects… increasing reliability and efficiency of treatment GI ...
Joint research of biomarkers on platform technology of GI Innovation, GI-SMARTTM and SpAC9 Pipeline, AI-powered biomarker discovery platform of CellKey Prediction of drug response on next generation immuno-oncology, personalized cancer treatment effects… increasing Reliability and efficiency of treatment GI ...
Martin Rottman, Professor of Clinical Microbiology at Université de VersaillesSt Quentin and Director of the Innovative Biomarkers Platform at Assistance Publique - Hôpitaux de Paris, France, was carried out at Hôpital Raymond Poincaré. ...
Co-founders and biomedical engineers Corey Centen and Sarah Smith founded Bodyport to develop a novel biomarker platform that could detect early signs of cardiovascular disease, incorporating proprietary sensor technology into a bathroom scale form factor. Rather than relying on wearables, the Bodyport Scale is designed to detect cardiac signals and ...
Digital biomarker awards support technology solutions for early detection of Alzheimer’s and related dementias Data platform enables researchers using digital tools to share their findings for benchmarking, analysis and use across research projects ADDF’s Diagnostics Accelerator has $50 million in commitments from leading philanthropists Leonard ...
The blood analysis was carried out using PerkinElmer's BioXPRESSION™ Biomarker platform and Predictive Diagnostic's proprietary BAMF™ technology to identify patterns of proteins and peptides that distinguish Alzheimer's disease patients from those without clinical signs. ...